V Square Quantitative Management LLC Has $434,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

V Square Quantitative Management LLC lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 15.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,475 shares of the biotechnology company’s stock after selling 275 shares during the period. V Square Quantitative Management LLC’s holdings in Axon Enterprise were worth $434,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. increased its stake in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after acquiring an additional 212,401 shares during the period. Sands Capital Management LLC increased its stake in Axon Enterprise by 0.6% during the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock valued at $679,060,000 after acquiring an additional 16,347 shares during the period. Norges Bank bought a new position in Axon Enterprise during the fourth quarter valued at about $195,406,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 5.1% during the fourth quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after acquiring an additional 35,528 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Axon Enterprise by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock valued at $150,027,000 after acquiring an additional 15,840 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of recent research reports. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Bank of America started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price for the company. Jefferies Financial Group started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price for the company. Robert W. Baird increased their target price on Axon Enterprise from $355.00 to $360.00 and gave the stock an “outperform” rating in a report on Wednesday, August 7th. Finally, Morgan Stanley increased their price target on Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, April 26th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $358.08.

Get Our Latest Analysis on AXON

Axon Enterprise Trading Up 0.8 %

Shares of AXON stock traded up $2.80 during trading hours on Thursday, reaching $373.37. The company had a trading volume of 45,767 shares, compared to its average volume of 522,996. The company has a 50 day moving average of $306.26 and a 200 day moving average of $298.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. The firm has a market cap of $28.22 billion, a price-to-earnings ratio of 108.35, a P/E/G ratio of 7.42 and a beta of 0.95. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $375.95.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm’s revenue was up 34.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.80 EPS. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.36 EPS for the current year.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 478 shares of Axon Enterprise stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $286.04, for a total value of $136,727.12. Following the sale, the director now owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Julie A. Cullivan sold 993 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the transaction, the director now owns 4,553 shares in the company, valued at approximately $1,282,671.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 478 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total value of $136,727.12. Following the completion of the transaction, the director now owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,471 shares of company stock valued at $1,145,795. 6.10% of the stock is owned by company insiders.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.